GlobeNewswire Inc.·Apr 12·Kessler Topaz Meltzer & Check, LlpImmunityBio Faces Securities Fraud Suit Over Anktiva Cancer ClaimsImmunityBio faces securities fraud lawsuit after FDA warning over false Anktiva claims. Stock plunged 21%. Investor deadline May 26, 2026. IBRXsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 12·Kessler Topaz Meltzer & Check, LlpPinterest Faces Securities Fraud Class Action Over Revenue Misstatements, Tariff ClaimsLaw firm files class action lawsuit against Pinterest for allegedly making false statements about advertising revenues and tariff impacts. Stock dropped 16.8% after disappointing earnings. PINSsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 11·Rosen Law FirmPFSI Stock Plunges 33% After Q4 Results; Class Action Investigation LaunchedPennyMac Financial Services ($PFSI) stock crashed 33.3% following weak Q4 earnings, prompting securities litigation over allegedly misleading disclosures. PFSIsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 11·Rosen Law FirmImmutep Stock Plummets 82.6% on Failed Clinical Trial; Class Action Probe LaunchedImmutep's $IMMP stock crashed 82.6% after discontinuing Phase III trial for lead drug candidate. Rosen Law Firm investigating potential securities violations and class action claims. IMMPsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 10·Hagens BermanImmunityBio Faces Major Securities Lawsuit Over FDA Warning on Drug ClaimsImmunityBio faces securities lawsuit after FDA warning letter regarding misleading efficacy claims for immunotherapy drug Anktiva, triggering 21% stock plunge. IBRXinvestor lossessecurities class action
GlobeNewswire Inc.·Apr 10·The Rosen Law FirmGSI Technology Stock Plummets 14% on AI Chip Capability AllegationsGSI Technology faces securities investigation after allegations of misleading statements about AI chip capabilities. Stock fell 14.2% following February disclosure. GSITsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 10·Portnoy Law FirmStellantis Faces Class Action Over $24B Reset, Stock Plummets 23%Portnoy Law Firm files class action against Stellantis for alleged misstatements on electrification prospects. Stock crashed 23% after €22.2B reset announcement. STLAsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 9·Robbins LlpTrip.com Faces Class Action Over Undisclosed Antitrust Risks as Stock Tumbles 19.4%Robbins LLP filed class action against $TCOM for allegedly concealing antitrust risks. Stock dropped 19.4% after January 2026 antitrust probe disclosure. TCOMclass action lawsuitregulatory risk
GlobeNewswire Inc.·Apr 9·Portnoy Law FirmProfound Medical Under Investigation for $472K Revenue OverstatementThe Portnoy Law Firm is investigating Profound Medical for securities fraud following a $472,000 revenue overstatement in Q1 2024 that required financial restatement. PROFsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 9·Portnoy Law FirmTechTarget Faces Securities Fraud Investigation Over $70-110M Accounting ErrorsPortnoy Law Firm investigates TechTarget for securities fraud following accounting errors tied to Informa Tech acquisition, triggering expected $70-110M goodwill impairment charges. TTGTsecurities fraudclass action
GlobeNewswire Inc.·Apr 9·Robbins LlpUPST Faces Class Action Over AI Model Claims as Stock Plummets on Guidance MissClass action filed against Upstart Holdings for allegedly misleading investors about AI lending platform performance. Stock fell 9.71% after Q3 miss and guidance cut. UPSTclass action lawsuitshareholder rights
GlobeNewswire Inc.·Apr 8·Robbins Llp$STLA Under Fire: Stellantis Faces Class Action Over €22B Charge and Earnings MissRobbins LLP files class action against Stellantis alleging investor fraud over 2025 earnings projections. Stock plunged 23.69% after €22B charge announcement. STLAsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 8·Robbins Geller Rudman & Dowd LlpSoleno Therapeutics Faces Class Action Over Undisclosed Drug Safety IssuesClass action filed against $SLNO for allegedly failing to disclose safety concerns about DCCR drug. Stock fell sharply after August 2025 short report and September patient death disclosure. SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 8·Bragar Eagel & Squire, P.C.ADMA Biologics Faces Short-Seller Allegations of Revenue InflationLaw firm investigates $ADMA over channel stuffing claims. Stock plummets 16.63% after short report alleges actual 2025 revenues declined 3% despite reported 20% growth. ADMAsecurities investigationstock price decline
GlobeNewswire Inc.·Apr 8·Bragar Eagel & Squire, P.C.Weis Markets Faces Securities Investigation Over $71.5B Inventory RestatementWeis Markets restates 3 years of financials due to inventory errors; stock falls 7.16%. Securities investigation launched by Bragar Eagel & Squire. WMKsecurities investigationstock price decline
GlobeNewswire Inc.·Apr 8·Glancy Prongay Wolke & Rotter LlpNektar Therapeutics Hit With Securities Fraud Lawsuit Over Failed Alopecia TrialNektar Therapeutics ($NKTR) faces securities fraud lawsuit after Phase 2b alopecia trial failed due to enrollment violations, triggering 7.8% stock decline. NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 8·The Rosen Law FirmHub Group Accounting Error Sparks 18% Stock Plunge, Triggers Securities InvestigationHub Group restates Q1-Q3 2025 financials after accounting error. Stock drops 18.3% on disclosure; law firm investigates shareholder claims. HUBGinvestor lossessecurities class action
GlobeNewswire Inc.·Apr 8·Kahn Swick & Foti, Llc$SMCI Plummets 33% After DOJ Indicts Executives Over $2.5B China Server DiversionSuper Micro Computer faces DOJ indictment for allegedly diverting $2.5B in AI servers to China. Stock collapsed 33%, triggering class action lawsuits with May 26 application deadline. SMCIsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 7·Glancy Prongay Wolke & Rotter LlpKyndryl Stock Plummets 54.9% Amid Fraud Lawsuit Over Accounting FailuresLaw firm sues Kyndryl ($KD) for alleged securities fraud involving misstated financials and undisclosed problems. Stock crashed 54.9% after executive departures and SEC inquiry. KDsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 7·Robbins Geller Rudman & Dowd LlpStellantis Faces Class Action Over Electrification Claims as Stock Plummets 23%Class action lawsuit filed against $STLA for alleged misstatements on electrification prospects. February 2026 €22.2B reset triggered 23% stock decline; lead plaintiffs sought. IBRXDRVNSTLAsecurities fraudclass action lawsuit